Perrigo CoPRGO +2.85%44 Pretax Margin % is -42.15% as of Mar. 2026. GuruFocus rates PRGO with a GF Score™ of 44/100 and a GF Value™ of $25.00 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 955 Drug Manufacturers companies, Perrigo Co ranks worse than 85.34% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Perrigo Co's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-409 Mil. Perrigo Co's Revenue for the
three
months ended in Mar. 2026 was $969 Mil. Therefore, Perrigo Co's pretax margin for the quarter that ended in Mar. 2026 was -42.15%.
The historical rank and industry rank for Perrigo Co's Pretax Margin % or its related term are showing as below:
PRGO'
s Pretax Margin % Range Over the Past 10 Years
Min: -91.81 Med: -0.02 Max: 6.25
Current: -41.04
PRGO's Pretax Margin % is ranked worse than 85.34% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs PRGO: -41.04
Perrigo Co (NYSE:PRGO) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Perrigo Co Pretax Margin % Related Terms
Perrigo Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Perrigo Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRGO vs AMLX, HROW, ANIP: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (PRGO) has a Pretax Margin % of -42.15% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Perrigo Co and its competitors. According to the industry distribution chart, Perrigo Co ranks #815 out of 955 companies in the Drug Manufacturers industry, placing it in the top 85.3%.
Is Perrigo Co's Pretax Margin % too high?
Perrigo Co's current Pretax Margin % is -42.15%. Based on the distribution chart, Perrigo Co ranks #815 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Perrigo Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's Pretax Margin % compare to AMLX and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #815 out of 955 companies for Pretax Margin %. This places Perrigo Co in the lower half of its industry. The industry median Pretax Margin % is 7.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current Pretax Margin % is -42.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Based on GuruFocus' analysis, Perrigo Co (PRGO) is currently considered Possible Value Trap. The stock's GF Value™ is $25.00, compared to a current price of $9.76 — trading 61% below its estimated fair value. The current Pretax Margin % is -42.15%. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Perrigo Co (PRGO), the current Pretax Margin % is -42.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (PRGO) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of $9.76 is trading 61% below its estimated GF Value™ of $25.00.
GuruFocus considers Perrigo Co to be Possible Value Trap.
Key valuation signals for PRGO:
Pretax Margin %: -42.15%
GF Value™: $25.00 vs. price of $9.76 (61% below fair value)
No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for PRGO
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRGO has been successfully added to your 
